Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

768
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
768
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

632
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
632
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning curve and perioperative outcomes: a retrospective cohort study between synchronous and combined inflatable mediastinoscope-laparoscopic radical esophagectomy.

Surgical endoscopy·2026
Same author

IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery.

Database : the journal of biological databases and curation·2026
Same author

Intravenous Immunoglobulin Reveals a Novel Protective Mechanism: Targeting the GBP5-Driven Pyroptosis Axis in Experimental Colitis.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Application of 3D Slicer-based three-dimensional visual surgical planning in endoscopic optic canal decompression surgery: a prospective randomised controlled study.

BMC medical imaging·2026
Same author

Metabolism and regulation of chlorophyll and carotenoids in tomato fruits.

Horticulture research·2026
Same author

The complete treatment and management of brain metastases in a patient with limited-stage small cell lung cancer under molecular residual disease (MRD) monitoring: a case report.

AME case reports·2026

Related Experiment Video

Updated: Mar 26, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K

Drug-resistant tuberculosis control in China: progress and challenges.

Qian Long1,2, Yan Qu3, Henry Lucas4

  • 1Global Health Research Center, Duke Kunshan University, Kunshan, China. qian.long@dku.edu.cn.

Infectious Diseases of Poverty
|January 30, 2016
PubMed
Summary

China faces a high burden of multidrug-resistant tuberculosis (MDR-TB), disproportionately affecting rural populations. Sustained government funding and social protection are crucial for universal access to effective TB treatment and control.

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Area of Science:

  • Public Health
  • Infectious Disease Control
  • Health Systems Research

Background:

  • China has the world's second-highest burden of multidrug-resistant tuberculosis (MDR-TB).
  • A comprehensive health system reform was initiated in 2009, including MDR-TB prevention and control planning.

Purpose of the Study:

  • To analyze the challenges and strategies for MDR-TB prevention and control in China.
  • To evaluate the financial burden on households affected by MDR-TB.
  • To assess the role of health system reforms and external funding in addressing MDR-TB.

Main Methods:

  • Review of national TB/MDR-TB control policies and initiatives.
  • Analysis of epidemiological data on TB and MDR-TB prevalence.
  • Assessment of financial impact on patient households.
  • Evaluation of international and domestic funding mechanisms.

Main Results:

  • MDR-TB disproportionately impacts the poor and rural populations, particularly in less developed regions.
  • Interrupted or inappropriate TB treatment contributes to high MDR-TB rates.
  • Households face significant financial burdens due to treatment and associated costs.
  • Global Fund and Bill & Melinda Gates Foundation initiatives aim to improve MDR-TB management and reduce costs.

Conclusions:

  • Current efforts, while positive, may be insufficient without increased domestic funding and appropriate incentives for healthcare providers.
  • Sustained government financing and social health protection are critical for universal access to TB treatment.
  • Addressing financial barriers and ensuring appropriate treatment are key to reducing MDR-TB incidence and improving management.